21 August 2023
Several vaccines associated with reduced risk of Alzheimer’s disease in adults 65 and older
Prior vaccination against tetanus and diphtheria, with or without pertussis (Tdap/Td); herpes zoster (HZ), better known as shingles; and pneumococcus are all associated with a reduced risk for developing Alzheimer’s disease, according to new research from UTHealth Houston.
15 August 2023
Older women at risk for Alzheimer’s disease may benefit from yoga
Researchers at UCLA Semel Institute for Neuroscience and Human Behavior, using a type of MRI that measures activity in regions and subregions of the brain, found that Kundalini yoga, which combines movement and meditation and focuses on breathing, mantra recitation and mental visualization, increased connectivity in an area of the brain that can be impacted by stress and is associated with memory decline.
7 August 2023
New Early Alzheimer’s treatment Shows Improvement in Cognition
Dr. Heather Sandison, a leading expert in Alzheimer's Disease and Related Dementia (ADRD) care, has recently published a groundbreaking study in the Journal of Alzheimer's Disease, highlighting significant improvements in cognitive function among individuals with cognitive decline. The study is the second to employ a multimodal, individualized care plan and offers further hope for managing and potentially reversing cognitive impairment.
7 August 2023
FSU researcher finds potential new tool for early identification of dementia risk
Research at the Florida State University College of Medicine has identified a potential low-cost method for predicting if a person is at risk of developing dementia. By analyzing data from nearly 13,000 subjects who participated in a long-term aging study, researchers found that an interviewer’s rating of a cognitively healthy person’s memory successfully predicted the likelihood of developing dementia over a 15-year period.
4 August 2023
Antioxidants & Redox Signaling: Celebrating Outstanding Contributions in Science
Scientific research has always been at the forefront of driving progress and innovation, transforming the way we understand the world around us. Within this vast landscape of knowledge, certain areas have stood out for their significant impact on human health and well-being.
10 July 2023
2023 Alzheimer Award Goes to Henning Tiemeier, MD, PhD, and Rosanne Freak-Poli, PhD
The Journal of Alzheimer’s Disease (JAD) is pleased to announce the joint recipients of the 2023 Alzheimer Award are Henning Tiemeier and Rosanne Freak-Poli. The 2023 winning paper, "Loneliness, Not Social Support, Is Associated with Cognitive Decline and Dementia Across Two Longitudinal Population-Based Cohorts", presents important insights into the impact of poor social health, specifically loneliness, on cognitive decline and risk of dementia in older adults.
29 June 2023
Open access sister journal to JAD receives first impact factor
The Journal of Alzheimer's Disease Reports (JAD Reports) and its publisher IOS Press are proud to announce that JAD Reports has received its first impact factor of 3.2 according to Clarivate's 2023 edition of the Web of Science Journal Citation Reports™ (Emerging Sources Citation Index). This represents an impressive first number for this quality open access publication.
23 June 2023
Phone Menu Test Detects Who May Be at Risk of Alzheimer’s Disease
A new study by investigators from Mass General Brigham has found that a brief, simulated task of navigating a phone menu can detect the earliest changes in daily functioning in people at risk of developing Alzheimer’s disease. Investigators found that an older adult’s performance on the test, which can be completed in a matter of minutes, was associated with the hallmarks of Alzheimer’s disease pathology, including amyloid and tau depositions in the brain. The findings could help inform prevention trials testing treatments for Alzheimer’s disease before pronounced symptoms of cognitive decline begin.
22 June 2023
Significant Correlation Found between Vitreous Human Biomarkers and Alzheimer’s Disease
New research from Boston Medical Center found a significant correlation between biomarkers in the vitreous humor of the eye and pathologically confirmed cases of Alzheimer’s disease (AD) and Chronic Traumatic Encephalopathy (CTE) in post-mortem brain and eye tissue. This exploratory study indicates that biomarkers in the vitreous humor may serve as a proxy for neuropathological disease.
19 June 2023
New UCI-led research shows people who live to be 90+ with superior thinking skills are resilient to Alzheimer’s pathology in their brains
A University of California, Irvine-led team of researchers have discovered that the oldest-old, those who live to be 90+ and have superior cognitive skills, have similar levels of brain pathology as Alzheimer’s patients, however, they also have less brain pathology of other neurodegenerative diseases that cause memory and thinking problems.
- Comment
|